GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Bioperfectus Technologies Co Ltd (SHSE:688399) » Definitions » Gross Profit

Jiangsu Bioperfectus Technologies Co (SHSE:688399) Gross Profit : ¥267.5 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Jiangsu Bioperfectus Technologies Co Gross Profit?

Jiangsu Bioperfectus Technologies Co's gross profit for the three months ended in Sep. 2024 was ¥55.1 Mil. Jiangsu Bioperfectus Technologies Co's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ¥267.5 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Jiangsu Bioperfectus Technologies Co's gross profit for the three months ended in Sep. 2024 was ¥55.1 Mil. Jiangsu Bioperfectus Technologies Co's Revenue for the three months ended in Sep. 2024 was ¥90.6 Mil. Therefore, Jiangsu Bioperfectus Technologies Co's Gross Margin % for the quarter that ended in Sep. 2024 was 60.83%.

Jiangsu Bioperfectus Technologies Co had a gross margin of 60.83% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 8 years, the highest Gross Margin % of Jiangsu Bioperfectus Technologies Co was 82.67%. The lowest was 60.62%. And the median was 79.63%.

Warning Sign:

Jiangsu Bioperfectus Technologies Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -6.2%.


Jiangsu Bioperfectus Technologies Co Gross Profit Historical Data

The historical data trend for Jiangsu Bioperfectus Technologies Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Bioperfectus Technologies Co Gross Profit Chart

Jiangsu Bioperfectus Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 236.11 1,349.82 1,962.69 3,354.96 257.68

Jiangsu Bioperfectus Technologies Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.40 91.48 64.63 56.27 55.13

Competitive Comparison of Jiangsu Bioperfectus Technologies Co's Gross Profit

For the Biotechnology subindustry, Jiangsu Bioperfectus Technologies Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Bioperfectus Technologies Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Bioperfectus Technologies Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Jiangsu Bioperfectus Technologies Co's Gross Profit falls into.



Jiangsu Bioperfectus Technologies Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Jiangsu Bioperfectus Technologies Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=403.179 - 145.498
=257.7

Jiangsu Bioperfectus Technologies Co's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=90.64 - 35.507
=55.1

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥267.5 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Jiangsu Bioperfectus Technologies Co's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=55.1 / 90.64
=60.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Jiangsu Bioperfectus Technologies Co  (SHSE:688399) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Jiangsu Bioperfectus Technologies Co had a gross margin of 60.83% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Jiangsu Bioperfectus Technologies Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Jiangsu Bioperfectus Technologies Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Bioperfectus Technologies Co Business Description

Traded in Other Exchanges
N/A
Address
3rd floor, Block G19, No.1 Yaocheng Avenue, Jiangsu, Taizhou, CHN
Jiangsu Bioperfectus Technologies Co Ltd is engaged in product development, production and sales of disease prevention and control, female genital micro-ecological testing and tumor screening. Its products portfolio includes Fever respiratory pathogen detection series, Fever with a rash pathogen test series, Fever with bleeding pathogen test series, Foodborne diseases and diarrheal pathogen detection and Other types of pathogen detection series.
Executives
Jin Jing Supervisors

Jiangsu Bioperfectus Technologies Co Headlines

No Headlines